Consistent with other findings, basal-like breast cancer patients demonstrated significantly elevated ZWINT expression levels (0.4245 ± 0.8502, n = 1880) compared to non-basal-like cases (−0.0868 ± 0.9233, n = 8036) (P < 0.0001) (Fig. 4e). This evidence concerns the gene ZWINT and breast carcinoma.